Denis Chem Lab MD, chairman, board of directors and AGM
BSE: 537536Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹60.02.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹83 Cr2,891st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 10.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 0.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 4.17%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 10.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.05
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,780
Denis Chem Lab board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonDINESHCHANDRA BHIKHABHAI PATELRelated to the promoter
- Managing directorHIMANSHU CHAITANYA PATEL
- Company Secretary and Compliance OfficerAnal Desai
6 directors3 independent1 executive2 non-executive
- DINESHCHANDRA BHIKHABHAI PATEL · ChairpersonNon-executive · joined Apr 2007 · reappointed Sep 2025 · 1 listed board · 1 committee seat
- HIMANSHU CHAITANYA PATEL · Managing directorExecutive · joined May 1981 · reappointed Aug 2026 · 1 listed board · 1 committee seat
- ANAR HIMANSHU PATELNon-executive · joined Mar 1998 · reappointed Sep 2024 · 1 listed board · 1 committee seat, 1 as chair
- HEMENDRAKUMAR CHAMANLAL SHAHIndependent · joined Feb 2020 · reappointed Feb 2025 · 60 months as independent · 3 listed boards · 3 as independent · 3 committee seats
- DIPAK NARENDRAPRASAD PATELIndependent · joined Sep 2024 · reappointed Sep 2024 · 60 months as independent · 2 listed boards · 1 as independent · 4 committee seats
- HEMANG PATELIndependent · joined Sep 2024 · reappointed Sep 2024 · 60 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 25 Sep 20266 of 6 present3 independent · 42 days in between
- 13 Aug 20266 of 6 present3 independent · 14 days in between
- 29 Jul 20266 of 6 present3 independent · 59 days in between
- 30 May 20266 of 6 present3 independent
Audit Committee
Chair HEMANG PATEL
DIPAK NARENDRAPRASAD PATEL, DINESHCHANDRA BHIKHABHAI PATEL
- 13 Aug 20263 of 3 present2 independent · 14 days in between
- 29 Jul 20263 of 3 present2 independent · 59 days in between
- 30 May 20263 of 3 present2 independent
Nomination and remuneration committee
Chair HEMANG PATEL
DIPAK NARENDRAPRASAD PATEL, ANAR HIMANSHU PATEL
- 29 Jul 20263 of 3 present2 independent
Stakeholders Relationship Committee
Chair ANAR HIMANSHU PATEL
DIPAK NARENDRAPRASAD PATEL, HIMANSHU CHAITANYA PATEL
- 9 Jul 20263 of 3 present1 independent · 44 days in between
- 25 May 20263 of 3 present1 independent
Corporate Social Responsibility Committee
Chair HEMANG PATEL
ANAR HIMANSHU PATEL, HIMANSHU CHAITANYA PATEL
- 29 Jul 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- Shah & Shah AssociatesPeer-review certificate valid to Jul 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Denis Chem Lab AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Denis Chem Lab dividend history
Annual general meeting, 25 Sep 2026
7,398 shareholders on the register on 18 Sep 2026; present: 3 promoters and 38 others; votes counted by KASHYAP R. MEHTA / KASHYAP R. MEHTA & PARTNERS.The company's voting result (opens in a new tab)
- Adoption of Audited Financial Statements of the Company for the financial year ended 31st March, 2026, together with the Reports of the Board of Directors and the Auditors thereon.Ordinary99.31% for0.69% against
Against: promoters 0.00% · institutions 0.00% · other public 1.78%
Turnout: all 63.91% · promoters 100.00% · institutions 0.00% · other public 40.87%
- Declare a dividend of Rs. 2.50 per Equity Share, for the financial year ended on 31st March, 2026.Ordinary99.31% for0.69% against
Against: promoters 0.00% · institutions 0.00% · other public 1.78%
Turnout: all 63.91% · promoters 100.00% · institutions 0.00% · other public 40.87%
- Re-appoint Ms. Anar Patel (DIN - 01335025), liable to retire by rotation and being eligible, offers herself for re-appointmentOrdinary99.30% for0.70% against
Against: promoters 0.00% · institutions 0.00% · other public 1.78%
Turnout: all 63.91% · promoters 100.00% · institutions 0.00% · other public 40.87%
- Consideration of Remuneration payable to Cost Auditors of the Company pursuant to Section 148 of the Companies Act, 2013.Ordinary99.31% for0.69% against
Against: promoters 0.00% · institutions 0.00% · other public 1.78%
Turnout: all 63.91% · promoters 100.00% · institutions 0.00% · other public 40.87%
Appointment of M/s. Kashyap R. Mehta & Partners, Practising Company Secretaries as a Secretarial Auditors of the Company for a term of five (5) consecutive years from financial year 2026-27 to 2030-31.MoreLess
Ordinary99.31% for0.69% againstAgainst: promoters 0.00% · institutions 0.00% · other public 1.78%
Turnout: all 63.91% · promoters 100.00% · institutions 0.00% · other public 40.87%
Re-appointment of Dr. Himanshu C. Patel (DIN: 00087114) as Managing Director of the Company not liable to retire by rotation, for a period of 3 years with effect from 1st August, 2026 to 31st July, 2029 who has attained of 70 years and is aged 72 years at present.MoreLess
SpecialPromoters have an interest in it99.31% for0.69% againstAgainst: promoters 0.00% · institutions 0.00% · other public 1.78%
Turnout: all 63.91% · promoters 100.00% · institutions 0.00% · other public 40.87%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Tax disputes
Reported in the filing for the quarter to Sep 2026.
- Tax disputeOFFICE OF COMISSIONER OF CENTRAL GST AND EXCISE – AHMEDABADSince 29 Jan 2004PENDING APPEAL BEFORE-CESTAT
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.